Tags : BRIDGE LAB031


Evotec Signs an Agreement with Sanofi for Novel Drug Development

Shots: Sanofi and Evotec launches BRIDGE LAB031, designed to convert academic research into drug discovery candidates for multiple therapeutic areas. BRIDGE is a public-private partnership combining academia, biotech and venture capital into pharma for early-stage projects The companies will focus on development of multiple small molecule programmes through lead optimization for next three years Evotec […]Read More